DaiLuMD

Anesthesiology • Houston, TX

Instructor, Neurology-Brigham & Women's Hospital, Harvard Medical School

Join to view full profile

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lu's full profile

Already have an account?

Office
1500 Citywest Blvd
Ste 300
Houston, TX 77042
Phone+1 713-620-4000

Fax+1 713-458-4229

Education & Training

Baylor College of MedicineResidency, Anesthesiology, 1995 - 1999
Shanghai Medical UniversityClass of 1987

Certifications & Licensure

AZ State Medical License 1999 - Present
OR State Medical License 2001 - Present
UT State Medical License 1900 - Present
TX State Medical License 1998 - 2026
American Board of Anesthesiology Anesthesiology

Clinical Trials

A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia Start of enrollment: 2018 Oct 09
Completed
Phase 3
A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 Start of enrollment: 2019 Jan 09
Completed
Phase 1
A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults. Start of enrollment: 2019 Jan 06
Completed
Phase 1
A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults Start of enrollment: 2020 Mar 30
Withdrawn
Phase 1
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules Start of enrollment: 2018 Dec 14
Completed
Phase 1
A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics Start of enrollment: 2017 Oct 24
Completed
Phase 1
A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch Start of enrollment: 2018 Feb 07
Completed
Phase 1
A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery Subjects Start of enrollment: 2019 Mar 22
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

28 citations
Translational potential of allosteric modulators targeting the cannabinoid CB 1 receptor
Dai Lu, Sri Sujana Immadi, Zhixing Wu, Debra A. Kendall
Acta Pharmacologica Sinica. 2019-03-01
20 citations
Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.
Chang-jiang Qiao, Hamed I. Ali, Kwang H. Ahn, Srikanth Kolluru, Debra A. Kendall
European Journal of Medicinal Chemistry. 2016-10-04
27 citations
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.
Dai Lu, Rachel Dopart, Debra A. Kendall
Cell Stress & Chaperones. 2016-01-01